{rfName}
Ch

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Mellado, MAuthor

Share

February 10, 2014
Publications
>
Article
No

Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells

Publicated to:JOURNAL OF IMMUNOLOGY. 159 (11): 5576-5584 - 1997-12-01 159(11), DOI:

Authors: Frade, Jmr; Frade, J M; Mellado, M; del Real, G; Gutierrez-Ramos, JC; Gutierrez-Ramos, J C; Lind, P; Martinez, C; Martinez-A, C

Affiliations

Abstract

We have derived anti-human CCR2-specific mAbs by immunization with synthetic peptides corresponding to CCR2 sequences presumably involved in the interaction with its ligand(s). The characterization of these mAbs includes the ability to recognize the CCR2 receptor specifically, as well as the function based on their ability to promote Ca2+ influx or to block MCP-1-induced Ca2+ influx and chemotaxis. One mAb (MCP-1 R02) that is directed to the NH2 terminal domain of the CCR2 receptor has MCP-1 agonist activity, and two that recognize the third extracellular domain (MCP-1R04 and MCP-1 R05) have MCP-1 antagonist activity. We analyzed the presence of CCR2 in several PBL and tonsil-derived leukocyte populations and found expression of this receptor in monocytes, activated T cells, and, surprisingly, in B cells. CCR2 receptor expression in B cells was further corroborated in Southern blot using CCR2-specific probes. Moreover, both MCP-1 and the agonist mAb trigger specific B cell migration via a PTX-sensitive mechanism, indicating the presence of a functional CCR2 receptor in these cells.

Keywords

Antibodies, monoclonalCell lineHumansMale

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal JOURNAL OF IMMUNOLOGY due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 1997, it was in position 7/117, thus managing to position itself as a Q1 (Primer Cuartil), in the category Immunology.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-07-19:

  • WoS: 136
  • Scopus: 146
  • Europe PMC: 8

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: United States.